Company: NDRA
Filing Date: 2025-10-23
Form Type: 8-K
Source: 0001654954-25-012084
Chunk: 0

Company: ENDRA Life Sciences Inc.
Filing Date: 2025-10-23
Form: 8-K
Item: Item 7.01
Chunk 0
---
Item 7.01

Regulation FD Disclosure.

On October 23, 2025, ENDRA Life Sciences Inc. (the “ Company”) issued a press release announcing the closing of the private placement offering (the “ Offering”) to implement a digital asset treasury (the “ DAT”) as previously disclosed on the Current Report on Form 8-K filed with the Securities and Exchange Commission (the “ Commission”) on October 15, 2025.

A copy of the press release is included as Exhibit 99.1 hereto and is incorporated herein by reference.

The information under this Item 7.01, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, (the “ Exchange Act”) or otherwise subject to the liabilities of that section, and shall not be deemed to be incorporated by reference into the filings of the Company under the Securities Act or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

Item 8.01Other Events.